Ali Behbahani Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
Jun 28 2021
BUY
Open market or private purchase
$19,950,000 $19.0 p/Share
1,050,000
Jun 28 2021
BUY
Conversion of derivative security
-
6,642,298

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
> 10% Shareholder
MRKR
Marker Therapeutics, Inc. Healthcare
> 10% Shareholder
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
Director
NKTX
Nkarta, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
Director
TRVI
Trevi Therapeutics, Inc. Healthcare
> 10% Shareholder
UTRS
MINERVA SURGICAL INC Healthcare
Director
MTCR
Metacrine, Inc. Healthcare
> 10% Shareholder
AKUS
Akouos, Inc. Healthcare
> 10% Shareholder
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
SVRA
Savara Inc Healthcare
> 10% Shareholder
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
AB

Ali Behbahani

Timonium, MD

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE